Correction: The anti-rheumatic drug, leflunomide, synergizes with MEK inhibition to suppress melanoma growth
Metrics: PDF 464 views | ?
1 School of Biological Sciences, University of East Anglia, Norwich Research Park, Norwich, NR4 7TJ, UK
2 School of Pharmacy, University of East Anglia, Norwich Research Park, Norwich, NR4 7TJ, UK
3 Present address: Division of Cancer Sciences, School of Medicine, Ninewells Hospital and Medical School, University of Dundee, Dundee, DD1 9SY, UK
4 Norwich Medical School, University of East Anglia, Norwich Research Park, Norwich, NR4 7TJ, UK
5 Present address: Pharmacy and Biomedical Sciences, Liverpool John Moores University, Liverpool, L3 3AF, UK
Published: November 27, 2018
This article has been corrected: The correct Author name is given below:
Stephen D. Robinson
Original article: Oncotarget. 2018; 9:3815-3829. DOI: https://doi.org/10.18632/oncotarget.23378.
All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 3.0 License.